Journal Club Articles
1.
Twenty-five year follow up for breast cancer incidence and mortality of the
Canadian National Breast Screening Study: Randomized Screening Trial
Miller et.al; BMJ 2014
2.
Effect of ACEI and ARB on All-Cause Mortality, Cardiovascular Death and
Cardiovascular Events in Patients with Diabetes Mellitus. A Meta-Analysis
Cheng et.al; JAMA 2014
3.
Age-Adjusted D-Dimer Cutoff Levels to Rule out Pulmonary Embolism. The
ADJUST-PE Study
Righini, Van Es et. Al.; JAMA 2014
4.
Changes in Mortality after Massachusetts Health Care Reform
Sommers, Long et. Al; Annals of Internal Medicine; May 6th, 2014
5.
Health Care-Associated Infection after Red Blood Cell Transfusion. A
Systematic Review and Meta-Analysis
Rohde et.al; JAMA 2014
6.
Aspirin in Patients Undergoing Noncardiac Surgery
Devereaux et al; NEJM April 2014
7.
Albumin Replacement in Patients with Severe Sepsis or Septic Shock
Caironi et al; NEJM April 2014
8.
A Randomized Trial of Protocol-Based Care for Early Septic Shock
The ProCESS Investigators; NEJM March 18th, 2014
9.
High versus Low Blood-Pressure Target in Patients with Septic Shock
Asfar et.al; NEJM March 18th, 2014
10. Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic
Shock
Rivers et.al; NEJM Nov 8th, 2001
11. Cost-Effectiveness of Genotype-Guided and Dual Antiplatelet Therapies in
Acute Coronary Syndrome.
Kazi MD, et. Al. Annals of Internal Medicine, Feb 2014
12. Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary
Syndromes without ST-Segment Elevation (The CURE Trial).
NEJM 2001
13. Long Term Mortality after Screening for Colorectal Cancer.
Shaukat A, Mongin SJ, Geisser MS, et al. NEJM 2013
14. Upper Airway Stimulation for Obstructive Sleep Apnea.
Strollo, Soose, Maurer et al. NEJM 2014
15. Bariatric Surgery vs. non-surgical treatment for obesity.
Gloy, Bhatt, et al. BMJ 2013
16. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care
units (PRORATA trial): a multicentre randomised controlled trial
Bouadma et al; Lancet, 2010
17. Body-Mass Index and Mortality among Adults with Incident Type 2 Diabetes
Tobias et al; NEJM Jan 16th, 2014
18. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in
Adults. Report From the Panel Members Appointed to the Eighth Joint
National Committee (JNC 8)
JAMA December 2013
19. Heart Association Task Force on Practice Guidelines Cardiovascular Risk in
Adults: A Report of the American College of Cardiology/American 2013
ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce
Atherosclerotic
Circulation 2013
20. Worsening Trends in the Management and Treatment of Back Pain
JAMA 2013
21. Effects of Vitamin D supplements on bone mineral density: A systematic review
and meta-analysis
22. Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
(NEJM).
November 2013
23. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with
Type 2 Diabetes and Nephropathy.
REENAL Study (NEJM) 2001
24. Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
(NEJM).
November 2013
25. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with
Type 2 Diabetes and Nephropathy.
REENAL Study (NEJM) 2001
26. Aggressive Fluid and Sodium Restriction in Acute Decompensated Heart
Failure
JAMA, June 2013
27. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL
Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
The Lancet, June 1999
28. Short-term vs Conventional Glucocorticoid Therapy in Acute Exacerbations of
Chronic Obstructive Pulmonary Disease. The REDUCE Randomized Clinical
Trial.
JAMA, May 2013
29. Effect of Home Blood Pressure Telemonitoring and Pharmacist Management on
Blood Pressure Control: A Cluster Randomized Clinical Trial
Margolis et. al; JAMA July 3, 2013
30. Therapies for Active Rheumatoid Arthritis after Methotrexate Failure
O’Dell et al; NEJM July 25, 2013
31. Diagnostic Blood Loss From Phlebotomy and Hospital-Acquired Anemia
During Acute Myocardial Infarction
Salisbury et al; Arch Intern Med; October 10, 2011
32. “Effect of hormone replacement therapy on cardiovascular events in recently
postmenopausal women”
BMJ
33. “Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal
Women” (results from the Women’s Health Initiative)
JAMA
34. “Associations Between Reduced Hospital Length of Stay and 30 Day
Readmission Rate & Mortality”
Annals of Internal Medicine
35. Dietary and Supplemental Calcium Intake and Cardiovascular Disease
Mortality
The National Institutes of Health
36. Blood Pressure and Mortality in U.S. Veterans with Chronic Kidney Disease
Annals of Internal Medicine
37. Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
The New England Journal of Medicine
38. Association Between Chlorthalidone Treatment of Systolic Hypertension and
Long-term Survival
JAMA, December 21, 2011
39. Screening for Lung Cancer with Low-Dose Computed Tomography: A
Systematic Review to Update the U.S. Preventive Services Task Force
Recommendation
Annals of Internal Medicine
40. Twenty-five year follow up for breast cancer incidence and mortality of the
Canadian National Breast Screening Study: Randomized Screening Trial
Miller et.al; BMJ 2014
41. Effect of ACEI and ARB on All-Cause Mortality, Cardiovascular Death and
Cardiovascular Events in Patients with Diabetes Mellitus. A Meta-Analysis
Cheng et.al; JAMA 2014
42. Twenty-five year follow up for breast cancer incidence and mortality of the
Canadian National Breast Screening Study: Randomized Screening Trial
Miller et.al; BMJ 2014
43. Effect of ACEI and ARB on All-Cause Mortality, Cardiovascular Death and
Cardiovascular Events in Patients with Diabetes Mellitus. A Meta-Analysis
Cheng et.al; JAMA 2014
44. Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD
Criner et. al
NEJM June 14, 2014
45. Atrial Fibrillation in Patients with Cryptogenic Stroke
Gladstone et. al
NEJM June 26, 2014
46. Once weekly Dalbvancin versus conventional therapy for skin infection
Boucher, et. al
NEJM June 5th, 2014
47.
Pregnancy Incidence and Outcomes Among Women Receiving Pre-exposure
Prophylaxis for HIV Prevention: A Randomized Clinical Trial
Nelly R. Mugo, MBChB, MPH1,2,3; et. al
http://jama.jamanetwork.com/article.aspx?articleid=1889140&resultClick=3
48. Telecare Collaborative Management of Chronic Pain in Primary Care: A
Randomized Clinical Trial
Kurt Kroenke, MD1,2,3; Erin E. Krebs, MD4,5; Jingwei Wu, MS6; Zhangsheng Yu,
PhD6; Neale R. Chumbler, PhD7; Matthew J. Bair, MD1,2,3
http://jama.jamanetwork.com/article.aspx?articleid=1887761&resultClick=3
49. Efficacy of Varenicline Combined With Nicotine Replacement Therapy vs
Varenicline Alone for Smoking Cessation: A Randomized Clinical Trial
Coenraad F. N. Koegelenberg, MD, PhD1; et.al
http://jama.jamanetwork.com/article.aspx?articleid=1886188
50. Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
Jennifer S. Temel, M.D., Joseph A. Greer, Ph.D., et.al
N Engl J Med 2010; 363:733-742August 19, 2010DOI: 10.1056/NEJMoa1000678
http://www.nejm.org/doi/full/10.1056/NEJMoa1000678
51. Dabigatran versus Warfarin in Patients with Atrial Fibrillation (RE-LY Trial)
Stuart J. Connolly, M.D., Michael D. Ezekowitz, M.B., Ch.B., et.al and the RE-LY
Steering Committee and Investigators
N Engl J Med 2009; 361:1139-1151 September 17, 2009
52. Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection:
Results from Two Multinational, Randomized, Controlled Trials
Stuart Johnson, Thomas Louie, et. al for the Polymer Alternative for CDI Treatment
(PACT) investigators
Clinical Infectious Diseases; July 2014
53. The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a
CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy
Michiel Coppens, John W. Eikelboom et. Al
European Heart Journal, September 2012
54. The Risk of Melanoma in Airline Pilots and Cabin Crew
Martina Sanlorenzo, MD et.al
JAMA Dermatol. Published online September 03, 2014
55. Cardiovascular Risk and Events in 17 Low, Middle and High-Income Countries
S. Yusuf et.al
NEJM, August 28, 2014
56. Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
J.J. McMurray et. al
NEJM, September 11th, 2014
57. The Risk of Melanoma in Airline Pilots and Cabin Crew
Martina Sanlorenzo, MD et. al
JAMA Dermatol. Published online September 3, 214
58. Cardiovascular Risk and Events in 17 Low, Middle and High-Income Countries
S. Yusuf et. al
NEJM, August 28, 2014
59. Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
J.J. McMurray et. al
NEJM, September 11, 2014
60. A Controlled Trial of Renal Denervation for Resistant Hypertension
Deepak L. Bhatt, M.D., M.P.H., David E. Kandzari, M.D et.al for the SYMPLICITY
HTN-3 Investigators
NEJM, March 29th, 2014
61. Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes
who do not have Adequate Glycemic Control With Metformin Plus
Sulfonylurea
G. Schernthaner, J. Gross et.al
Diabetes Care, April 5, 2013
62. Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year
Outcomes
Philip R. Schauer, M.D., Deepak L. Bhatt, M.D., M.P.H., et.al for the STAMPEDE
Investigators
NEJM, March 31, 2014
63. Multitarget Stool DNA Testing for Colorectal-Cancer Screening
Thomas F. Imperiale, et. Al
NEJM April 3rd, 2014
64. A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
B. Joseph Elmunzer, et. al
NEJM April 12, 2012
65.
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without
Cirrhosis
Kris V. Kowdley, et. al
NEJM May 15, 2014
66. Goal-Directed Resuscitation for Patients with Early Septic Shock
The ARISE Investigators and the ANZICS Clinical Trials Group*
October 1st, 2014
67. Fractional Flow Reserve–Guided PCI for Stable Coronary Artery Disease
Bernard De Bruyne, M.D., Ph.D. et.al
NEJM September 2014
68. Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
The HPS2-THRIVE Collaborative Group*
NEJM July 2014
69. Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in
Japanese Patients 60 years or Older with Atherosclerotic Risk Factors
Y. Ikeda et. al, JAMA, November 17, 2014
http://jama.jamanetwork.com/article.aspx?articleid=1936801
70. Tamoxifen for prevention of breast cancer: extended long-term follow-up of the
IBIS-I breast cancer prevention trial
J. Cuzick et.al, Lancet, December 2014
http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(14)71171-4/abstract
71. A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of
Cardiovascular Disease in Women
P. Ridker et.al, NEJM, March 200
http://www.nejm.org/doi/full/10.1056/NEJMoa050613
72. The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain:
A Systematic Review for a National Institutes of Health Pathways to Prevention
Workshop
Roger Chou, MD et. Al
Annals of Internal Medicine, Feb 17th, 2015
73.
Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines
Andrew E. Moran, M.D., M.P.H., Michelle C. Odden, Ph.D., et.al
N Engl J Med January 29, 2015
74.
Perioperative Atrial Fibrillation and the Long-term Risk of Ischemic Stroke
Gino Gialdini, MD1; Katherine Nearing, MD2; et.al
JAMA, August 13th, 2015
75. Continuous Proton Pump Inhibitor Therapy and the Associated Risk of
Recurrent Clostridium difficile Infection
Emily G. McDonald, MD et.al
JAMA, March 2, 2015
76. Association of NSAID Use With Risk of Bleeding and Cardiovascular Events in
Patients Receiving Antithrombotic Therapy After Myocardial Infarction
Anne-Marie Schjerning Olsen, MD et.al
JAMA Feb 24, 2015
77. Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality,
Major Bleeding, and Intracranial Hemorrhage A Meta-analysis
Saurav Chatterjee, MD et.al
JAMA, June 18, 2014
78.
Antibiotic Treatment Strategies for Community-Acquired Pneumonia in
Adults
Douwe F. Postma, M.D et. Al
NEJM, April 2nd, 2015
79. Trial of Early, Goal-Directed Resuscitation for Septic Shock
Paul R. Mouncey, M.Sc., Tiffany M. Osborn, M.D et.al
NEJM, April 2nd, 2015
80. Outcomes of Anatomical versus Functional Testing for Coronary Artery
Disease
Pamela S. Douglas, M.D., et.al
NEJM, April 2nd, 2015
81.
Prednisolone or Pentoxifylline for Alcoholic Hepatitis
Mark R. Thursz, M.D et.al
NEJM, April 23rd, 2015
82.
Association of Early Imaging for Back Pain with Clinical Outcomes in Older
Adults
Jeffrey Jarvik, MD et.al
JAMA March 17, 2015
83. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic
review and meta-analysis of randomised placebo controlled trials
Gustavo C Machado, PhD, et.al
BMJ, March 2015
84. Clindamycin versus Trimethoprim–Sulfamethoxazole for Uncomplicated Skin
Infections
Loren G. Miller, M.D., M.P.H., et.al
NEJM March 19, 2015
85.
Systemic corticosteroids for acute exacerbations of chronic obstructive
pulmonary disease.
Walters JA et.al
Cochrane Database Syst Rev. 2014.
86.
Second-generation drug-eluting stent implantation followed by 6- versus 12month dual antiplatelet therapy: The SECURITY randomized clinical trial.
Colombo A, Chieffo A, Frasheri A, et al.
J Am Coll Cardiol. 2014
87. Effect of a retrievable inferior vena cava filter plus anticoagulation vs
anticoagulation alone on risk of recurrent pulmonary embolism: a randomized
clinical trial.
Mismetti P et. al
JAMA. 2015 Apr 28;313(16):1627-35.
88. Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During
Warfarin Interruption for Invasive Procedures
Nathan P. Clark, PharmD1,2; Daniel M. Witt, PharmD1,3; et.al
JAMA Intern Med. Published online May 26, 2015
89. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic
vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled
trial
Louis Bernard, Aurélien Dinh, Idir Ghout, David Simo, Valerie Zeller, et.al on behalf
of the Duration of Treatment for Spondylodiscitis (DTS) study group*
Lancet, Vol 385 March 7, 2015
90. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight
Management
Xavier Pi-Sunyer, M.D., Arne Astrup, M.D., D.M.Sc., Ken Fujioka, M.D., Frank
Greenway, M.D.,et.al for the SCALE Obesity and Prediabetes NN8022-1839 Study
Group*
NEJM, July 2, 2015
91. Effects of intensive blood-pressure control in type 2 diabetes mellitus
Cushman WC, Evans GW, Byington RP, et al.
N Engl J Med. 2010;362(17):1575-1585.
92. Blood-pressure control for renoprotection in patients with non-diabetic chronic
renal disease (REIN-2): Multicentre, randomised controlled trial
Ruggenenti P, Perna A, Loriga G, et al.
Lancet. 2005;365(9463):939-946
93. Telmisartan, ramipril, or both in patients at high risk for vascular events.
Yusuf S, Teo KK, Pogue J, et al.
N Engl J Med. 2008;358(15):1547-1559.
94. Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
Jennifer S. Temel, M.D., Joseph A. Greer, Ph.D., et.al
N Engl J Med August 19, 2010; 363:733-742
95. Patients’ Expectations about Effects of Chemotherapy for Advanced Cancer
Jane C. Weeks, M.D, et. al
N Engl J Med 2012;367:1616-25.
96. Chemotherapy Use, Performance Status, and Quality of Life at the End of
Life
Holly G. Prigerson, PhD et. Al
JAMA Oncol. July 23, 2015.
97. Six Months vs Extended Oral Anticoagulation After a First Episode of
Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial
Francis Couturaud, MD, PhD; Olivier Sanchez, MD, PhD et.al
JAMA July 7 2015
98. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
The INSIGHT START Study Group
NEJM August 27, 2015
99. Screening for Occult Cancer in Unprovoked Venous Thromboembolism
Marc Carrier, M.D., Alejandro Lazo-Langner, M.D., et.al
NEJM August 20, 2015
100. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
James D. Douketis, M.D., Alex C. Spyropoulos MD, et.al
NEJM August 27, 2015
101. Terlipressin Plus Albumin Versus Midodrine and Octreotide Plus Albumin in
the Treatment of Hepatorenal Syndrome: A Randomized Trial
Marta Cavallin, et. Al
Hepatology, August 2015
102. Intravascular Complications of Central Venous Catheterization by Insertion
Site
Jean-Jacques Parienti, et. al
NEJM, September 25, 2015
103. Effect Of Intravenous Albumin On Renal Impairment and Mortality in Patients
With Cirrhosis And Spontaneous Bacterial Peritonitis
Pau Sort, et.al
NEJM, 1999
104. Calcium intake and risk of fracture: systematic review.
Bolland MJ, Leung W, Tai V, et al.
BMJ. 2015 Sep 29
105. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman B, Wanner C, Lachin JM, et al.
N Engl J Med. 2015 Sep 17
106. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the
optimal treatment for drug-resistant hypertension (PATHWAY-2
Williams B, MacDonald TM, Morant S, et al.
Lancet. 2015 Sep 18
107. Naproxen With Cyclobenzaprine, Oxycodone/Acetaminophen, or Placebo for
Treating Acute Low Back Pain
Benjamin W. Friedman, MD et.al
JAMA October 20, 2015
108. Beta-Blocker-Associated Risks in Patients With Uncomplicated Hypertension
Undergoing Noncardiac Surgery.
Jorgensen ME, Hlatky MA, Kober L, et al.
JAMA, October 5, 2015
109. A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group
NEJM, November 26, 2015
110. Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart
Disease
Steven P. Sedlis, M.D. et.al
NEJM, November 12, 2015
111. Stroke and recurrent hemorrhage associated with antithrombotic treatment
after gastrointestinal bleeding in patients with atrial fibrillation: nationwide
cohort study.
Staerk L, Lip GY, Olesen JB, et al.
BMJ Nov 2015
112. Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk
Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a
National Primary Care Database.
van den Ham HA, Klungel OH, Singer DE, et al.
J Am Coll Cardiol. 2015 Oct
113. A Comparison of Rate Control and Rhythm Control in Patients with Atrial
Fibrillation
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
Investigators
N Engl J Med 2002
114. Randomized study of basal-bolus insulin therapy in the inpatient management
of patients with type 2 diabetes (RABBIT 2 trial)
Umpierrez GE1, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, Puig
A, Mejia R
Diabetes Care. 2007 Sep;30(9):2181-6. Epub 2007 May 18.
115. Intensive blood-glucose control with sulphonylureas or insulin compared with
conventional treatment and risk of complications in patients with type 2
diabetes (UKPDS 33)
UK Prospective Diabetes Study (UKPDS) Group.
Lancet. 1998 Sep 12
116. Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2
Diabetes
Rodney A. Hayward, M.D., Peter D. Reaven, M.D., et.al for the VADT Investigators
NEJM June 4, 2015
117. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
The INSIGHT START Study Group
NEJM August 27, 2015
118. Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for
HIV-1 Prevention A Randomized Trial
Lindsey R. Baden, MD; Etienne Karita, MD et.al
Annals of Internal Medicine Feb 2016
119. Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis
David R. Boulware, M.D., M.P.H., et.al for COAT Trial Team
NEJM June 26 2014
120. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
The INSIGHT START Study Group
NEJM August 27, 2015
121. Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for
HIV-1 Prevention A Randomized Trial
Lindsey R. Baden, MD; Etienne Karita, MD et.al
Annals of Internal Medicine Feb 2016
122. Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis
David R. Boulware, M.D., M.P.H., et.al for COAT Trial Team
NEJM June 26 2014
123. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
The INSIGHT START Study Group
NEJM August 27, 2015
124. Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for
HIV-1 Prevention A Randomized Trial
Lindsey R. Baden, MD; Etienne Karita, MD et.al
Annals of Internal Medicine Feb 2016
125. Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis
David R. Boulware, M.D., M.P.H., et.al for COAT Trial Team
NEJM June 26 2014
126. Validation of the International Medical Prevention Registry on Venous
Thromboembolism Bleeding Risk Score
MAJ David C. Hostler et.al
Chest 2015
127. Trimethoprim–Sulfamethoxazole versus Placebo for Uncomplicated Skin
Abscess
David A. Talan et.al
NEJM March 3, 2016
128. HbA1c over-testing and overtreatment among US adults with controlled type 2
diabetes, 2001-13: observational population based study
Rozalina G McCoy et.al
BMJ 2015
129. Validation of the International Medical Prevention Registry on Venous
Thromboembolism Bleeding Risk Score
MAJ David C. Hostler et.al
Chest 2015
130. Trimethoprim–Sulfamethoxazole versus Placebo for Uncomplicated Skin
Abscess
David A. Talan et.al
NEJM March 3, 2016
131. HbA1c over-testing and overtreatment among US adults with controlled type 2
diabetes, 2001-13: observational population based study
Rozalina G McCoy et.al
BMJ 2015
132. Validation of the International Medical Prevention Registry on Venous
Thromboembolism Bleeding Risk Score
MAJ David C. Hostler et.al
Chest 2015
133. Trimethoprim–Sulfamethoxazole versus Placebo for Uncomplicated Skin
Abscess
David A. Talan et.al
NEJM March 3, 2016
134. HbA1c over-testing and overtreatment among US adults with controlled type 2
diabetes, 2001-13: observational population based study
Rozalina G McCoy et.al
BMJ 2015
135. Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial
Fibrillation (SPINAF)
Michael D. Ezekowitz, M.D., Ph.D., Samuel L. Bridgers, M.D. et.al
NEJM 1992
136. Rivaroxaban versus Warfarin in Non-Valvular Atrial Fibrillation (ROCKET
AF)
Manesh R. Patel, M.D., Kenneth W. Mahaffey, M.D. et.al
NEJM Sept 8, 2011
137. Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial
Fibrillation (SPINAF)
Michael D. Ezekowitz, M.D., Ph.D., Samuel L. Bridgers, M.D. et.al
NEJM 1992
138. Rivaroxaban versus Warfarin in Non-Valvular Atrial Fibrillation (ROCKET
AF)
Manesh R. Patel, M.D., Kenneth W. Mahaffey, M.D. et.al
NEJM Sept 8, 2011
139. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy
Eric J. Velazquez, M.D., Kerry L. Lee, Ph.D., et.al for the STICHES Investigators*
NEJM April 21, 2016
140. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular
Disease
Yusuf S, Bosch J, Dagenais G, et al. for the HOPE-3 Investigators
NEJM April 2, 2016
141. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon, M.D., Michael A. Blazing, M.D., et.al for the IMPROVE-IT
Investigators
NEJM June 18, 2015
142. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy
Eric J. Velazquez, M.D., Kerry L. Lee, Ph.D., et.al for the STICHES Investigators*
NEJM April 21, 2016
143. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular
Disease
Yusuf S, Bosch J, Dagenais G, et al. for the HOPE-3 Investigators
NEJM April 2, 2016
144. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon, M.D., Michael A. Blazing, M.D., et.al for the IMPROVE-IT
Investigators
NEJM June 18, 2015
145. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy
Eric J. Velazquez, M.D., Kerry L. Lee, Ph.D., et.al for the STICHES Investigators*
NEJM April 21, 2016
146. Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular
Disease
Yusuf S, Bosch J, Dagenais G, et al. for the HOPE-3 Investigators
NEJM April 2, 2016
147. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon, M.D., Michael A. Blazing, M.D., et.al for the IMPROVE-IT
Investigators
NEJM June 18, 2015
148. The Third International Consensus Definitions for Sepsis and Septic Shock
(Sepsis-3)
Mervyn Singer, MD, FRCP1; Clifford S. Deutschman, MD, MS et. Al
JAMA Feb 23 2016
149. Nutritional Support and Outcomes in Malnourished Medical Inpatients: A
Systematic Review and Meta-analysis
Bally MR1, Blaser Yildirim PZ2, et. Al
JAMA Jan 2016
150. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular
Disease
Eva M. Lonn, M.D., Jackie Bosch, Ph.D et.al
NEJM April 2016
151. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk
Patients
Martin B. Leon, M.D., Craig R. Smith
NEJM April 2016
152. The Third International Consensus Definitions for Sepsis and Septic Shock
(Sepsis-3)
Mervyn Singer, MD, FRCP1; Clifford S. Deutschman, MD, MS et. Al
JAMA Feb 23 2016
153. Nutritional Support and Outcomes in Malnourished Medical Inpatients: A
Systematic Review and Meta-analysis.
Bally MR1, Blaser Yildirim PZ2, et. Al
JAMA Jan 2016
154. Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular
Disease
Eva M. Lonn, M.D., Jackie Bosch, Ph.D et.al
NEJM April 2016
155. Transcatheter or Surgical Aortic-Valve Replacement in IntermediateRisk Patients
Martin B. Leon, M.D., Craig R. Smith
NEJM April 2016
156. Invasive versus conservative strategy in patients aged 80 years or older
with NSTEMI or unstable angina pectoris (After Eighty study)
Nicolai Tegn, Michael Abdelnoor, et.al
Jan 12, 2016 (Lancet)
157. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic
Attack
S. Claiborne Johnston, M.D., Ph.D., Pierre Amarenco, M.D., et. Al for the
SOCRATES Steering Committee and Investigators
May 10, 2016 (NEJM)
158. Invasive versus conservative strategy in patients aged 80 years or older
with NSTEMI or unstable angina pectoris (After Eighty study)
Nicolai Tegn, Michael Abdelnoor, et.al
Jan 12, 2016 (Lancet)
159. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic
Attack
S. Claiborne Johnston, M.D., Ph.D., Pierre Amarenco, M.D., et. Al for the
SOCRATES Steering Committee and Investigators
May 10, 2016 (NEJM)